Bioceres (NYSE: BIOX) CFO files amended Form 3 insider ownership disclosure

Rhea-AI Filing Summary

Bioceres Crop Solutions Corp. CFO Ezequiel Simmermacher has filed an amended Form 3, which is the initial insider ownership report required for company officers. The amendment does not list any new stock transactions or derivative positions and instead updates previously reported ownership details.

Key Terms

Form 3/A, insider ownership, derivative positions

3 terms

Form 3/A regulatory

"has filed an amended Form 3, which is the initial insider ownership report"

An amended Form 3 (Form 3/A) is a corrected or updated disclosure filed with regulators that revises an insider’s initial report of their ownership in a public company — typically for officers, directors or large shareholders. Investors use it like a corrected inventory list: it clarifies who owns how many shares and whether earlier reports had errors, helping assess insider confidence, possible conflicts and the accuracy of ownership records that can affect stock valuation and trust.

insider ownership financial

"amended Form 3, which is the initial insider ownership report required for company officers"

derivative positions financial

"does not list any new stock transactions or derivative positions"

Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Simmermacher Ezequiel

(Last) (First) (Middle)

CALLE 64 S/N

(Street)

PILAR BUENOS AIRES 1629

(City) (State) (Zip)

ARGENTINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
01/05/2026

3. Issuer Name and Ticker or Trading Symbol
Bioceres Crop Solutions Corp. [ BIOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
04/20/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Ezequiel Simmermacher	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Bioceres (BIOX) Form 3/A filing report for the CFO?

The Form 3/A filing shows CFO Ezequiel Simmermacher’s amended initial insider ownership report. It updates his Section 16 disclosure for Bioceres Crop Solutions without listing any new stock or derivative transactions.

Does the Bioceres (BIOX) Form 3/A show any insider buying or selling?

No, the Form 3/A shows no insider buying or selling by the CFO. The transaction summary reports zero purchases, sales, exercises, gifts, or tax withholdings, indicating only an amendment to ownership disclosure, not new trading activity.

Who is the reporting person in the Bioceres (BIOX) Form 3/A filing?

The reporting person is Ezequiel Simmermacher, who serves as CFO of Bioceres Crop Solutions Corp. As an officer, he must report his beneficial ownership in company securities under Section 16 using Form 3 and any subsequent amendments.

What is the purpose of a Form 3/A amendment for Bioceres (BIOX)?

A Form 3/A amendment corrects or updates information from a prior Form 3 insider ownership filing. For Bioceres, this amendment adjusts the CFO’s reported holdings or related details without introducing new transactions or changes in trading activity.

Does the Bioceres (BIOX) Form 3/A include derivative securities information?

No, the Form 3/A derivative summary is empty for the CFO. This means the amendment does not list options, warrants, or other derivative positions, and focuses instead on updating previously reported ownership information, if any existed earlier.